Clinical significance of recombinant interferon-alpha 2 neutralizing antibodies in hepatitis patients.
Antonelli
G
G
Department of Biomedicine, University of Pisa, Italy.
Giannelli
G
G
Pistello
M
M
Maggi
F
F
Vatteroni
L
L
Currenti
M
M
Del Vecchio
S
S
Roffi
L
L
Pastore
G
G
Dianzani
F
F
D000918:Antibody Specificity; D000937:Antigen-Antibody Reactions; D002908:Chronic Disease; D006526:Hepatitis C / Q000188:drug therapy* / Q000276:immunology; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000276:immunology / Q000627:therapeutic use*; D011994:Recombinant Proteins; D012189:Retrospective Studies
D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins